Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.
Bonacini M, Rossi A, Ferrigno I, Muratore F, Boiardi L, Cavazza A, Bisagni A, Cimino L, De Simone L, Ghidini A, Malchiodi G, Corbera-Bellalta M, Cid MC, Zerbini A, Salvarani C, Croci S. Bonacini M, et al. Among authors: ferrigno i. J Autoimmun. 2024 Apr;144:103186. doi: 10.1016/j.jaut.2024.103186. Epub 2024 Feb 29. J Autoimmun. 2024. PMID: 38428111
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection.
Ferrigno I, Verzellesi L, Ottone M, Bonacini M, Rossi A, Besutti G, Bonelli E, Colla R, Facciolongo N, Teopompi E, Massari M, Mancuso P, Ferrari AM, Pattacini P, Trojani V, Bertolini M, Botti A, Zerbini A, Giorgi Rossi P, Iori M, Salvarani C, Croci S. Ferrigno I, et al. Inflamm Res. 2024 Apr;73(4):515-530. doi: 10.1007/s00011-024-01852-1. Epub 2024 Feb 3. Inflamm Res. 2024. PMID: 38308760
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells.
Dapporto F, De Tommaso D, Marrocco C, Piu P, Semplici C, Fantoni G, Ferrigno I, Piccini G, Monti M, Vanni F, Razzano I, Manini I, Montomoli E, Manenti A. Dapporto F, et al. Among authors: ferrigno i. J Immunol Methods. 2024 Jan;524:113588. doi: 10.1016/j.jim.2023.113588. Epub 2023 Nov 29. J Immunol Methods. 2024. PMID: 38040193 Free article.
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL, Croci S, Lonati PA, Pregnolato F, Spaggiari L, Besutti G, Bonacini M, Ferrigno I, Rossi A, Hetland G, Hollan I, Cugno M, Tedesco F, Borghi MO, Salvarani C. Meroni PL, et al. Among authors: ferrigno i. Autoimmun Rev. 2023 Jan;22(1):103232. doi: 10.1016/j.autrev.2022.103232. Epub 2022 Nov 19. Autoimmun Rev. 2023. PMID: 36414219 Free PMC article. Review.
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
Sicuranza A, Ferrigno I, Abruzzese E, Iurlo A, Galimberti S, Gozzini A, Luciano L, Stagno F, Russo Rossi A, Sgherza N, Cattaneo D, Zuanelli Brambilla C, Marzano C, Fava C, Mulas O, Cencini E, Santoni A, Sammartano V, Gozzetti A, Puccetti L, Bocchia M. Sicuranza A, et al. Among authors: ferrigno i. Front Oncol. 2022 Feb 1;12:835563. doi: 10.3389/fonc.2022.835563. eCollection 2022. Front Oncol. 2022. PMID: 35178353 Free PMC article.
15 results